Published in Blood Weekly, December 23rd, 2010
"To our knowledge this is the first use of spectral imaging technology for investigation of vascular disrupting agents....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.